Direxion Daily S&P Biotech Bull 3X Shares (LABU) — ()
Key Metrics
News
Top Performing Leveraged/Inverse ETFs: 11/16/2025
Published: by:
Sentiment: Neutral ()
Top Performing Leveraged/Inverse ETFs Last Week These were last week's top performing leveraged and inverse ETFs. Note that because of leverage, these kinds of funds can move quickly.
Read More
New FDA Director Could Sway Biotech ETFs
Published: by:
Sentiment: Positive ()
Biotech stocks could sway toward the upside with the appointment of a new director at the Federal Drug Administration's Center for Drug Evaluation and Research. Dr. Richard Pazdur will take …
Read More
Top Performing Leveraged/Inverse ETFs: 09/07/2025
Published: by:
Sentiment: Neutral ()
Top Performing Levered/Inverse ETFs Last Week These were last week's top performing leveraged and inverse ETFs. Note that because of leverage, these kinds of funds can move quickly.
Read More
Top Performing Leveraged/Inverse ETFs: 08/17/2025
Published: by:
Sentiment: Neutral ()
Top Performing Leveraged/Inverse ETFs Last Week These were last week's top performing leveraged and inverse ETFs. Note that because of leverage, these kinds of funds can move quickly.
Read More
About Direxion Daily S&P Biotech Bull 3X Shares LABU
The Direxion Daily S&P Biotech Bull and Bear 3X Shares seek daily investment results, before fees and expenses, of 300%, or 300% of the inverse (or opposite), of the performance of the S&P Biotechnology Select Industry Index. There is no guarantee the funds will achieve their stated investment objectives.